BNP PARIBAS FINANCIAL MARKETS - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 44 filers reported holding NEON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$11,682,000
+187.9%
4,425
+28.7%
0.00%
Q4 2019$4,058,000
+0.6%
3,439
+46.7%
0.00%
Q3 2019$4,032,000
-63.0%
2,344
+1.8%
0.00%
Q2 2019$10,911,000
-47.6%
2,302
-28.6%
0.00%
Q1 2019$20,827,000
+22786.8%
3,224
+17811.1%
0.00%
Q4 2018$91,000180.00%
Other shareholders
NEON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$25,718,0007.00%
HARVARD MANAGEMENT CO INC 505,871$1,335,0000.21%
ARMISTICE CAPITAL, LLC 1,050,000$2,772,0000.17%
Maven Securities LTD 381,150$1,006,0000.12%
Athanor Capital, LP 547,651$1,446,0000.09%
MONETA GROUP INVESTMENT ADVISORS LLC 102,652$271,0000.03%
TERRIL BROTHERS, INC. 19,300$51,0000.02%
MEEDER ASSET MANAGEMENT INC 5,878$15,0000.00%
ACADIAN ASSET MANAGEMENT LLC 94,908$251,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEON THERAPEUTICS INC shareholders